Welcome to our dedicated page for Regency Ctrs SEC filings (Ticker: REG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Regency Centers Corporation (REG) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as a shopping center-focused retail REIT and S&P 500 Index member. Regency Centers files reports for both the corporation and its operating partnership, Regency Centers, L.P., reflecting its structure as a REIT that owns, operates, and develops shopping centers in suburban trade areas.
Among the most informative documents for REG are its periodic reports and current reports on Form 8-K. These filings include earnings releases that discuss net income attributable to common shareholders, Nareit funds from operations (FFO), core operating earnings, same property net operating income (NOI) growth, leasing activity, and occupancy levels. They also provide updates on guidance for full-year performance metrics and details on development and redevelopment spending, acquisitions, and dispositions of shopping centers.
Regency Centers’ 8-K filings further cover capital structure and financing events, such as the issuance of senior unsecured notes, use of its revolving credit facility, and unregistered sales of equity securities through operating partnership units. Filings also document declarations of dividends on common stock and on the company’s 6.250% Series A and 5.875% Series B Cumulative Redeemable Preferred Stock, including payment rates and record dates.
Corporate governance matters appear in filings as well, including the election of directors to the board and committee assignments. Regulation FD disclosures and investor presentation updates are also furnished via Form 8-K, pointing investors to additional materials hosted by the company.
On Stock Titan, AI-powered tools summarize and highlight key points from Regency Centers’ SEC filings, helping readers interpret complex sections related to FFO, NOI, capital allocation, and securities issuance. Real-time updates from EDGAR, combined with AI summaries, make it easier to track new 10-K and 10-Q reports when they are filed, as well as insider and capital markets-related disclosures, without having to parse every line of the original documents.
HERMAN MICHAEL R reported acquisition or exercise transactions in this Form 4 filing.
Regency Centers Corp reported that Senior VP and General Counsel Michael R. Herman received a grant of 7,215 shares of restricted stock on March 4, 2026. The award was granted at a price of $0.00 per share as part of his equity compensation.
All 7,215 shares are held as direct ownership after the transaction. According to the terms, the restricted shares vest in four equal installments of 25% each year, beginning on March 4, 2027.
REGENCY CENTERS CORP Principal Accounting Officer Terah L. Devereaux received a grant of 3,173 restricted stock shares. The Form 4 reports this as an acquisition awarded on March 4, 2026 at a stated price of $0.00 per share.
The award vests over time, with 25% of the restricted stock scheduled to vest each year beginning on March 4, 2027. Following this grant, Devereaux is reported as directly owning 3,173 shares related to this award.
Regency Centers Corporation filed a current report to notify investors that it has made an updated investor presentation available. The presentation will be used at various conferences and meetings beginning on March 2, 2026 and over the following weeks.
The updated materials can be accessed through the investor relations section of Regency’s website at investors.regencycenters.com. The company notes that this presentation is being furnished under a disclosure item that is not treated as formally filed under securities laws, which limits its exposure to certain legal liabilities.
Regency Centers Corp Executive Chairman Martin E. Stein Jr. sold 10,000 shares of common stock in an open-market transaction at an average price of $76.3001 per share. The sale used a weighted average price, with individual trades executed between $76.10 and $76.42. After the sale, he directly holds 272,133 common shares, in addition to several indirect holdings through trusts, a family-controlled corporation, and general partnerships.
Regency Centers Corporation reported that its operating partnership, Regency Centers, L.P., completed a public offering of $450 million principal amount of 4.50% senior unsecured notes due 2033, priced at 99.376% of principal. The notes are unsecured, unsubordinated obligations of the partnership and are fully guaranteed by Regency.
The notes mature on March 15, 2033 and pay interest at 4.50% per year, with semiannual payments each March 15 and September 15, beginning September 15, 2026. Regency expects estimated net proceeds of about $443.3 million after underwriting discounts and expenses.
Regency plans to use the proceeds to reduce the balance on its line of credit, repay $100 million of 3.81% notes due May 11, 2026 at maturity, and for general corporate purposes, including capital expenditures, development and redevelopment projects, and future repayment of other outstanding debt.
REG submitted Form 144 notices reporting proposed sales of up to 10,000 common shares. The filing lists vested restricted shares of 9,175 shares vested 02/04/2026 (services rendered) and 825 shares vested 03/06/2015 (services rendered).
Regency Centers, L.P. is offering $450,000,000 of 4.50% Notes due March 15, 2033, with interest payable semi-annually on March 15 and September 15, beginning September 15, 2026. The notes are guaranteed by Regency Centers Corporation and were priced at 99.376% of par.
The issuer expects net proceeds of approximately $443.3 million, which will be used to reduce borrowings under its line of credit, repay the $100 million aggregate principal amount of the 2026 Notes at maturity and for general corporate purposes. Delivery is expected on or about February 23, 2026.
Regency Centers, L.P. is offering a series of unsecured notes guaranteed by Regency Centers Corporation, with interest payable semi-annually beginning in 2026 and initial denominations of $2,000 and integral multiples of $1,000 thereafter. The notes will be issued under Regency’s indenture and may be redeemed at the issuer’s option under the terms disclosed.
The prospectus supplement dated February 18, 2026 describes permitted uses of net proceeds, including repayment of $100 million aggregate principal amount of the 2026 Notes, reduction of borrowings under the line of credit and general corporate purposes such as capital expenditures and development projects.
Regency Centers Corporation entered into a new Equity Distribution Agreement and forward master confirmation with RBC Capital Markets and Royal Bank of Canada, adding them as a sales agent, forward seller and forward purchaser under its existing at-the-market equity program for common stock. The combined Equity Distribution Agreements permit offers and sales of shares of common stock from time to time having an aggregate offering price of up to $500,000,000. The structure allows Regency Centers to sell shares directly through sales agents or indirectly via forward sale agreements, with sales agents and forward sellers earning commissions of up to 2.0% of the gross sales price. Regency expects to primarily physically settle forward sales to receive cash proceeds later, but it may also choose cash or net share settlement, which could require delivering cash or shares to the forward purchasers.
Regency Centers Corporation is registering the offer and sale of up to $500,000,000 of its common stock through an ongoing at‑the‑market equity distribution program. The stock may be sold from time to time via multiple sales agents and through forward sale agreements with several major banks.
The company can issue shares directly or have forward purchasers borrow and sell shares as forward sellers, with total sales under the program capped at an aggregate sales price of $500,000,000. Net proceeds from direct issuances and physical settlement of forward sale agreements are intended to fund development and redevelopment projects, potential acquisitions, repayment of revolving credit facility borrowings and other debt, and general corporate purposes.
Regency notes that forward sale agreements may be physically, cash or net share settled, which can create dilution to earnings per share and return on equity or result in cash obligations. The filing also highlights REIT‑specific tax risks if significant gains from cash‑settled forwards were to affect REIT income tests, as well as broader dilution and stock‑price pressure risks from issuing additional common stock.